Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: Comparison of real-life effectiveness in the treatment of agitation

World Journal of Biological Psychiatry

Volumn 10, Issue 1, 2009, Pages 43-53

  Castle, David J ^a   Udristoiu, Tudor ^b   Kim, Chang Yoon ^c   Sarosi, Andrea ^d   Pidrman, Vladimir ^e   Omar, A Nasser ^f   Rosales, Juan Ignacio ^g   Melamed, Yuval ^h   Isik, Turgut ⁱ   Karagianis, Jamie ^j   Treuer, Tamas ^k  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c University of Ulsan College of Medicine   (South Korea)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f AIN SHAMS UNIVERSITY   (Egypt)

^g Clinica San Rafael Santa Ursula   (Mexico)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ Manisa Ruh Sagligi Ve Hastaliklari Hastanesi   (Turkey)

^j ELI LILLY AND COMPANY   (United States)

^k Lilly Hungaria Kft   (Hungary)

more..

Author keywords

Agitation; Bipolar disorder; Intramuscular antipsychotics; Olanzapine; Schizophrenia

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOPENTHIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE;

ACUTE DISEASE; ADULT; ARTICLE; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CULTURAL FACTOR; EXTRAPYRAMIDAL SYNDROME; FEMALE; HOSPITALIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RESTLESSNESS; SCHIZOPHRENIA; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BENZODIAZEPINES; BIPOLAR DISORDER; CLOPENTHIXOL; CROSS-CULTURAL COMPARISON; FEMALE; HALOPERIDOL; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 67749116179     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970802688051     Document Type: Article

References (22)

1. Bartko G. 2006. New formulations of olanzapine in the treatment of acute agitation. Neuropsychopharmacol Hung 8:171-178
2. Belgamwar RB, Fenton M. 2005. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses. Cochrane Database Syst Rev 2:CD003729
3. Binder RL, McNiel DE. 1999. Emergency psychiatry: contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms. Psychiatr Serv 50:1553-1554
4. Bodkin JA. 1990. Emerging uses for high-potency benzodiazepines in psychotic disorders. J Clin Psychiatry 51(Suppl):41-46 (Pubitemid 20159117)
5. Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, et al. 2002. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 59:441-448 (Pubitemid 34477680)
6. Bushe CJ, Taylor M, Mathew M. 2007. Intramuscular olanzapine-A UK case series of early cases. Ann Gen Psychiatry 6:11
7. Centorrino F, Meyers AL, Ahl J, Cincotta SL, Zun L, Gulliver AH, et al. 2007. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder. Hum Psychopharmacol 22:455-462 (Pubitemid 47611300)
8. Citrome L. 2007. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry 68:1876-1885
9. Cohen J. 1969. Statistical power analysis for the behavioral sciences. New York: Academic Press
10. Daniel J, Chamberlain J, Castle D. 2007. The pharmacological management of behavioural disturbance in psychosis: a naturalistic study. Australas Psychiatry 15:380-384 (Pubitemid 47399991)
11. Glazer WM. 2000. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality. J Clin Psychiatry 61(Suppl 3):16-21 (Pubitemid 30155229)
12. Guy W. 1976. ECDEU assessment manual for psychopharmacology, revised. Bethesda, MD: US Department of Health, Education, and Welfare
13. Jones B, Taylor CC, Meehan K. 2001. The efficacy of a rapidacting intramuscular formulation of olanzapine for positive symptoms. J Clin Psychiatry 62 Suppl 2:22-24
14. Kay S, Sevy S. 1990. Pyramidical model of schizophrenia. Schizophr Bull 16:537-545
15. Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, et al. 2001. A double-blind randomized comparison of the efficacy and safety of intramuscular injections of olanzapine lorazepam or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 21:389-397 (Pubitemid 32673028)
16. Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM Jr, et al. 2002. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology 26:494-504 (Pubitemid 34260999)
17. Mohr P, Pecenak J, Svestka J, Swingler D, Treuer T. 2005 Treatment of acute agitation in psychotic disorders. Neuroendocrinol Lett 26:327-335 (Pubitemid 41518772)
18. Pascual JC, Madre M, Puigdemont D, Oller S, Corripio I, Diaz A, et al. 2006. A naturalistic study: 100 consecutive episodes of acute agitation in a psychiatric emergency department. Actas Esp Psiquiatr 34:239-244 (Pubitemid 44196648)
19. Preval H, Klotz SG, Southard R, Francis A. 2005. Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study. Gen Hosp Psychiatry 27:140-144 (Pubitemid 40348779)
20. San L, Arranz B, Querejeta I, Barrio S, De la Gandara J, Perez V. 2006. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients. Eur Psychiatry 21:539-543 (Pubitemid 44855528)
21. Wright P, Birkett M, David S, Meehan K, Ferchland I, Alaka K, et al. 2001. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158:1149-1151 (Pubitemid 32623122)
22. Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, et al. 2003. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clin Ther 25:1420-1428.